PUBLIC CONTRACT · 2022
4180084/2022 - Aq. Central O99 - Octreotido 30 mg (12MG/ml frs /AMP 2,5 ml) po susp inj
- Contract value
- €6,383.86
- Signed on
- 2 February 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 8897632PUBLISHED SUBJECT
4180084/2022 - AQ. CENTRAL O99 - OCTREOTIDO 30 MG (12MG/ML FRS /AMP 2,5 ML) PO SUSP INJ
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- NOVARTIS FARMA – PRODUTOS FARMACÊUTICOS, S.A. · Tax ID 500063524
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €6,383.86
- Procedure base price
- €6,383.86
- Total effective price
- €6,383.86
- Publication date
- 11 February 2022
- Award date
- 2 February 2022
- Signing date
- 2 February 2022
- Performance period
- 5 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2021/47 - Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5783922
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.